Search
Search Results
##search.searchResults.foundPlural##
-
-
How I treat acute and persistent sickle cell pain
1836PDF: 1087HTML: 460 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1260PDF: 741HTML: 470 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1935PDF: 737HTML: 3101 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2340PDF: 1174HTML: 3583Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 395 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
1704PDF: 772HTML: 436 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4337PDF: 1872HTML: 17710 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3058PDF: 1565HTML: 392 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8871PDF: 5957HTML: 87459Fig.1b: 164Fig.1c: 165Fig.2a: 156Fig.2b: 161Fig.4: 169Fig.2c: 158Fig.3: 163Tab.1: 212Tab.2: 191Tab.3: 177Tab.4: 198Fig1a: 158 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2516PDF: 775HTML: 5175 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2478PDF: 915HTML: 15068 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1297HTML: 368PDF: 793 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1008PDF: 734HTML: 271 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7683PDF: 3980HTML: 7290 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3958PDF: 1012HTML: 3556Untitled: 164Cneo. Fig.1: 99Untitled: 89Untitled: 112Untitled: 114 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1732PDF: 1019HTML: 215 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2684PDF: 1754HTML: 3633Pellagatti Fig 1: 188Pellagatti Fig. 2: 188 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
936PDF: 947Suppl. Files: 614HTML: 95 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2112PDF: 1159HTML: 3684 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 980HTML: 5497 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
1996PDF: 1167Html: 259 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
562PDF: 280Suppl. Files: 103HTML: 96 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2092PDF: 1131HTML: 2572Study of serum haptoglobin level in thalassemia: 317Figures: 158 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4662PDF: 1742HTML: 2100 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
680PDF: 505HTML: 129 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2760PDF: 1538HTML: 216







